IE53035B1 - 1-(3halo-2-pyridinyl)piperazines, processes for their preparation and pharmaceutical compositions containing them - Google Patents
1-(3halo-2-pyridinyl)piperazines, processes for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IE53035B1 IE53035B1 IE1225/82A IE122582A IE53035B1 IE 53035 B1 IE53035 B1 IE 53035B1 IE 1225/82 A IE1225/82 A IE 1225/82A IE 122582 A IE122582 A IE 122582A IE 53035 B1 IE53035 B1 IE 53035B1
- Authority
- IE
- Ireland
- Prior art keywords
- halo
- fluoro
- compound
- piperazine
- pyridinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26712081A | 1981-05-26 | 1981-05-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE821225L IE821225L (en) | 1982-11-26 |
| IE53035B1 true IE53035B1 (en) | 1988-05-11 |
Family
ID=23017399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1225/82A IE53035B1 (en) | 1981-05-26 | 1982-05-21 | 1-(3halo-2-pyridinyl)piperazines, processes for their preparation and pharmaceutical compositions containing them |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0065757B1 (enExample) |
| JP (1) | JPS6055068B2 (enExample) |
| AT (1) | ATE11134T1 (enExample) |
| AU (1) | AU547319B2 (enExample) |
| CA (1) | CA1214467A (enExample) |
| DE (1) | DE3261827D1 (enExample) |
| DK (1) | DK234282A (enExample) |
| ES (4) | ES8306740A1 (enExample) |
| FI (1) | FI821739A7 (enExample) |
| GR (1) | GR76413B (enExample) |
| IE (1) | IE53035B1 (enExample) |
| IL (1) | IL65802A (enExample) |
| NO (1) | NO821730L (enExample) |
| NZ (1) | NZ200642A (enExample) |
| PH (1) | PH18686A (enExample) |
| PT (1) | PT74926B (enExample) |
| ZA (1) | ZA823611B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH056685U (ja) * | 1991-07-09 | 1993-01-29 | 株式会社ユアサコーポレーシヨン | 電池の艤装構造 |
| US7345096B2 (en) | 2002-10-15 | 2008-03-18 | Wyeth | Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
| US20040152710A1 (en) * | 2002-10-15 | 2004-08-05 | Deecher Darlene Coleman | Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
| US7419980B2 (en) | 2003-10-14 | 2008-09-02 | Wyeth | Fused-aryl and heteroaryl derivatives and methods of their use |
| US7402698B2 (en) | 2003-10-14 | 2008-07-22 | Wyeth | Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use |
| US7531543B2 (en) | 2003-10-14 | 2009-05-12 | Wyeth | Phenylpiperazine cycloalkanol derivatives and methods of their use |
| US7550485B2 (en) | 2003-10-14 | 2009-06-23 | Wyeth | Substituted N-heterocycle derivatives and methods of their use |
| US7365076B2 (en) | 2003-10-14 | 2008-04-29 | Wyeth | Substituted aryl cycloalkanol derivatives and methods of their use |
| US7524846B2 (en) | 2003-10-14 | 2009-04-28 | Wyeth | Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use |
| US7491723B2 (en) | 2003-10-14 | 2009-02-17 | Wyeth | Alkanol and cycloalkanol-amine derivatives and methods of their use |
| US7414052B2 (en) | 2004-03-30 | 2008-08-19 | Wyeth | Phenylaminopropanol derivatives and methods of their use |
| US7517899B2 (en) | 2004-03-30 | 2009-04-14 | Wyeth | Phenylaminopropanol derivatives and methods of their use |
| CN101671297B (zh) * | 2008-09-11 | 2012-05-09 | 上海药明康德新药开发有限公司 | 4-(3-碘-2-吡啶基)哌嗪类化合物的合成方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773951A (en) * | 1972-12-21 | 1973-11-20 | Miles Lab | Method of treating depression with 1-(2-pyridyl)piperazine |
| US4078063A (en) * | 1976-09-24 | 1978-03-07 | Merck & Co., Inc. | Piperazinylpyridines |
-
1982
- 1982-05-12 PH PH27279A patent/PH18686A/en unknown
- 1982-05-17 IL IL65802A patent/IL65802A/xx unknown
- 1982-05-17 FI FI821739A patent/FI821739A7/fi not_active Application Discontinuation
- 1982-05-17 NZ NZ200642A patent/NZ200642A/en unknown
- 1982-05-18 AU AU83802/82A patent/AU547319B2/en not_active Ceased
- 1982-05-18 PT PT74926A patent/PT74926B/pt unknown
- 1982-05-19 EP EP82104398A patent/EP0065757B1/en not_active Expired
- 1982-05-19 DE DE8282104398T patent/DE3261827D1/de not_active Expired
- 1982-05-19 AT AT82104398T patent/ATE11134T1/de not_active IP Right Cessation
- 1982-05-21 IE IE1225/82A patent/IE53035B1/en unknown
- 1982-05-24 GR GR68235A patent/GR76413B/el unknown
- 1982-05-25 CA CA000403610A patent/CA1214467A/en not_active Expired
- 1982-05-25 NO NO821730A patent/NO821730L/no unknown
- 1982-05-25 DK DK234282A patent/DK234282A/da not_active Application Discontinuation
- 1982-05-25 ES ES512533A patent/ES8306740A1/es not_active Expired
- 1982-05-25 ZA ZA823611A patent/ZA823611B/xx unknown
- 1982-05-26 JP JP57088171A patent/JPS6055068B2/ja not_active Expired
-
1983
- 1983-02-16 ES ES519854A patent/ES519854A0/es active Granted
- 1983-02-16 ES ES519856A patent/ES8403477A1/es not_active Expired
- 1983-02-16 ES ES519855A patent/ES519855A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ES8403476A1 (es) | 1984-03-16 |
| PT74926B (en) | 1985-05-16 |
| PT74926A (en) | 1982-06-01 |
| PH18686A (en) | 1985-08-29 |
| NZ200642A (en) | 1984-11-09 |
| AU8380282A (en) | 1982-12-02 |
| ES512533A0 (es) | 1983-06-01 |
| FI821739A7 (fi) | 1982-11-27 |
| DE3261827D1 (en) | 1985-02-21 |
| ES8403475A1 (es) | 1984-03-16 |
| JPS584766A (ja) | 1983-01-11 |
| AU547319B2 (en) | 1985-10-17 |
| DK234282A (da) | 1982-11-27 |
| IE821225L (en) | 1982-11-26 |
| ATE11134T1 (de) | 1985-01-15 |
| GR76413B (enExample) | 1984-08-10 |
| CA1214467A (en) | 1986-11-25 |
| ZA823611B (en) | 1983-12-28 |
| EP0065757B1 (en) | 1985-01-09 |
| EP0065757A1 (en) | 1982-12-01 |
| ES519855A0 (es) | 1984-03-16 |
| IL65802A (en) | 1985-12-31 |
| ES519856A0 (es) | 1984-03-16 |
| ES8306740A1 (es) | 1983-06-01 |
| ES8403477A1 (es) | 1984-03-16 |
| ES519854A0 (es) | 1984-03-16 |
| FI821739A0 (fi) | 1982-05-17 |
| JPS6055068B2 (ja) | 1985-12-03 |
| NO821730L (no) | 1982-11-29 |
| IL65802A0 (en) | 1982-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0065757B1 (en) | 1-(3-halo-2-pyridinyl)piperazines, processes for their preparation and pharmaceutical composition containing them | |
| CZ287381B6 (en) | Piperazine derivatives, processes and intermediates for their preparation, their use and pharmaceutical compositions based thereon | |
| CZ362599A3 (cs) | Indazolamidové sloučeniny jako serotoninergní přípravky | |
| EP0029707B1 (en) | Novel piperidine derivatives, method for the preparation thereof and pharmaceutical compositions containing them | |
| JPS6123790B2 (enExample) | ||
| FI105030B (fi) | Menetelmä terapeuttisesti käyttökelpoisten raseemisten tai optisesti aktiivisten 2-(bentso[d]isoksatsol- ja -iso-tiatsol-3-yyli)-perhydro-1H-pyrido[1,2-a]-pyratsiinijohdannaisten valmistamiseksi | |
| WO2001044193A1 (en) | 1,3,4-substituted piperidine analogs and uses thereof in treating addictions | |
| CZ377498A3 (cs) | Hexahydropyrido (4,3-b) indolové deriváty jako antipsychotická léčiva | |
| US4456604A (en) | 1-(3-Halo-2-pyridinyl) piperazine | |
| IL273748A (en) | Troueryl compounds as positive allosteric modulators for muscarinic m1 receptors | |
| JP2918508B2 (ja) | アゼチジン類 | |
| EP0736009B1 (en) | N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs | |
| US4442103A (en) | Treating sedation with 1-(3-substituted-2-pyridinyl) piperazines | |
| GB2249093A (en) | Piperidine derivatives and their use in pharmaceutical compositions | |
| CA3071084C (en) | Fluoropiperidine compounds as pure 5-ht6 receptor antagonists | |
| US4381302A (en) | (6aα,10aα,11aα)-2-(2-Pyridinyl)-1,3,4,6,6a,7,8,9,10,10a,11,11a-dodecahydro-2H-pyrazino]1,2-b]isoquinoline and derivatives | |
| EP0375536B1 (en) | Derivatives of 1,7'-(imidazo-(1,2-a)pyridine) 5'-(6'H) ones and process for their preparation | |
| JP3523887B2 (ja) | 縮合複素環ケトン誘導体、その製造法、中間体および剤 | |
| CS239947B2 (en) | Processing of new benzazepin derivatives | |
| JPS6153281A (ja) | １，３−置換−２−イミダゾリジノン誘導体，胃腸運動亢進剤及びその製造方法 | |
| HK40030967A (en) | Fluoropiperidine compounds as pure 5-ht6 receptor antagonists | |
| HK40030967B (en) | Fluoropiperidine compounds as pure 5-ht6 receptor antagonists | |
| IE47977B1 (en) | 6,7-di(loweralkoxy)-4-amino-2-(substituted piperidino)quinazolines |